DUBLIN — Adrenal-sparing surgery enables half of patients with multiple endocrine neoplasia type 2 (MEN2) and bilateral pheochromocytoma to gain 10 years without adrenal insufficiency yet still have a ...
Please provide your email address to receive an email when new articles are posted on . Neumann and colleagues from the International Bilateral Pheochromocytoma Registry Group analyzed registry data ...
The effect of adjuvant radiotherapy on survival in locoregional urothelial malignancies of the upper urinary tract. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract ...
Pheochromocytoma, a rare condition caused by a tumor in the adrenal medulla affecting the chromaffin cells, results in an excess production of catecholamines (epinephrine and norepinephrine) and ...
The First International Symposium on Pheochromocytoma, held in October 2005, included discussions about developments concerning these rare catecholamine-producing tumors. Recommendations were made ...
A randomized clinical trial of 70 patients found that an ultrasound-guided stellate ganglion block before laparoscopic ...
A 37-year-old man retained his kidney after surgeons removed an adrenal pheochromocytoma involving renal hilar vessels, using ...
Pheochromocytoma is a term used to refer to rare and mostly benign catecholamine-secreting tumors arising from the chromaffin cells found in the adrenal medulla or in the paraganglia (i.e.
ALTHOUGH the first case of pheochromocytoma associated with thyroid carcinoma was reported in 1932 1 it was not until 1952 that this combination of neoplasms was mentioned as occurring with unusual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results